ChineseInvestors.com, Inc. (CIIX) Primed to Capitalize on

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
375
ChineseInvestors.com, Inc. (CIIX) Primed to Capitalize on Thriving US Cannabis Market

- Cannabis market could reach $3 Billion by 2021, according to Green Wave Advisors
- Consilium Global Research sees international expansion niche for CIIX
- The Hemp Business Journal projects $450 million in sales from hemp-based products by 2020

ChineseInvestors.com, Inc. (OTCQB: CIIX) stands to benefit from the explosive growth of the cannabis market over the next four years. Cannabis could reach $2.1 billion in consumer sales by 2020, according to Forbes (http://nnw.fm/TGus4). An optimistic assessment is $3 billion by 2021, according to Green Wave Advisors (www.GreenWaveAdvisors.com).

CIIX offers educational and consulting services to Chinese investors, but, most recently, it has been pursuing a foothold in the cannabis market. In an effort to capitalize on the industry’s lofty projections, CIIX is opening a store in San Gabriel, California, from which to commercialize a line of hemp-oil based products. In addition to its San Gabriel store, the company also owns and operates an online store based in the free trade zone of Shanghai, China.

Research from Outco (http://nnw.fm/98etK), a licensed cultivator in Southern California, found that 38% of users and non-users of marijuana said they wanted to learn more about cannabidiol (CBD) oil. A large percentage of those surveyed also indicated that they are bullish on the CBD market, but a myriad of young brands are operating in the cannabis space. According to a report on CIIX from Consilium Global Research (http://nnw.fm/gZJM9), this is a nascent market. The research firm indicated that it will take significant capital to stand out and compete successfully, and resources will be needed to do business within an ever-evolving legal market.

The Consilium report also cited its finding that CIIX’s management team is “seasoned, proven and entrepreneurial,” with the vision and ability to execute. Further, it found positive benefits related to CIIX’s well-ingrained position within the Chinese-speaking community in the U.S. and abroad.

As a result, Consilium sees opportunities for CIIX in international expansion, with its large addressable market and the development of legal cannabis driving multiple years of sustainable growth. Further, the research firm sees the fact that the legal cannabis market has many entrants as an opportunity for CIIX if it can attract the necessary capital to compete.

For more information, visit the company’s website at www.ChineseInvestors.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Chineseinvestors.com Inc. (CIIX) Stock Research Links

CIIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading